Patients suffer as WHO politics continue

“Counterfeit” is a term that rarely needs defining, and yet controversy erupted again at the recent meeting of the World Health Organization’s Executive Board over just that. 
IMPACT (International Medical Products Anti-Counterfeiting Task Force) – a WHO partnership of major anti-counterfeiting players has recently proposed a new, stricter, definition of counterfeit medicines to help authorities combat [...]

The WHO and counterfeit medicines – an unresolved discussion

At last week’s WHO Executive Board meeting, discussion focused on a WHO report and draft resolution on counterfeit medical products.  The International Pharmaceutical Federation (FIP) was one of many health professional associations, NGO’s and other interested groups who joined the discussion.  Their full statement is included below, but some of the key points raised included:

A common comprehensive definition [...]